News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • No headlines were published in the past hour.
  • No new macroeconomic data releases occurred in the past hour.
  • No corporate earnings or major M&A announcements were reported in the past hour.
  • No central bank statements or policy actions appeared in the past hour.
  • Markets lack fresh, market-moving information this hour.
  • Monitor scheduled US openings and upcoming releases for the next potential catalysts.

Latest Articles

Streamex Corp. Clarifies and Refutes Inaccurate Claims Regarding Lock-Up Agreements; Co-Founders Morgan Lekstrom & Henry McPhie Enter into Voluntary 1 Year Lock-Up Agreements

Streamex Corp. Clarifies and Refutes Inaccurate Claims Regarding Lock-Up Agreements; Co-Founders Morgan Lekstrom & Henry McPhie Enter into Voluntary 1 Year Lock-Up Agreements

Streamex Corp. clarifies and disproves misleading third-party reports about the expiration of lock-up agreements related to its January 2026 financing. The company confirms that the previous lock-ups of certain shares held by co-founders Henry McPhie and Morgan Lekstrom were shorter than reported and that newly agreed voluntary one-year lock-ups ha…

First Economic Strains from Iran Conflict Hit UK, Exposing Policy Constraints

First Economic Strains from Iran Conflict Hit UK, Exposing Policy Constraints

Early economic effects from the Iran war are surfacing in Britain, with surging gas prices and downgrades to growth and inflation forecasts constraining both monetary and fiscal policymakers. The combination of higher energy costs, falling consumer confidence, and limited fiscal headroom raises difficult trade-offs for the Bank of England and the g…

Sportradar Files Its Annual Report on Form 20-F

Sportradar Files Its Annual Report on Form 20-F

Sportradar Group AG, a leading global sports technology company, announced the filing of its annual report on Form 20-F for the fiscal year ended December 31, 2025, with the SEC. The report is available to investors via the company’s website and SEC filings. Sportradar provides technology and services to sports federations, media, and betting opera…

SFL - Notice of Annual General Meeting 2026

SFL - Notice of Annual General Meeting 2026

SFL Corporation Ltd., a maritime shipping company listed on the NYSE, announced its Annual General Meeting to be held on May 11, 2026, with voting record date set for April 1, 2026. The company highlighted its stable dividend record since 2004 and provided a cautionary statement about risks and uncertainties affecting its business including market …

Aurora Mobile Partners with Soochow Securities to Advance Digital Transformation and Develop Intelligent Financial Services Platform

Aurora Mobile Partners with Soochow Securities to Advance Digital Transformation and Develop Intelligent Financial Services Platform

Aurora Mobile has entered into a strategic partnership with Soochow Securities to integrate its intelligent push notification platform, JPush, into Soochow Securities' 'Dongwu Xiucai' mobile app. This collaboration aims to improve real-time, secure delivery of financial notifications and personalized client communication, advancing Soochow's digita…

Legence Reports Fourth Quarter and Year End 2025 Financial Results

Legence Reports Fourth Quarter and Year End 2025 Financial Results

Legence Corp. reported record quarterly revenues of $737.6 million for Q4 2025, a 34.6% increase year-over-year, driven mainly by organic growth. The company posted a 53% increase in quarterly Adjusted EBITDA and a 49% increase in total backlog and awarded contracts to $3.7 billion. Strategic acquisitions including Bowers and Metrix enhance its mar…

Autolus Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates

Autolus Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates

Autolus Therapeutics reported fourth quarter and full year 2025 financial results highlighted by $74.3 million in net product revenue for their CAR T cell therapy AUCATZYL, approved for relapsed or refractory B-cell acute lymphoblastic leukemia (B-ALL). The company has launched AUCATZYL in the UK following positive NICE evaluation and expects conti…

Werewolf Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates

Werewolf Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates

Werewolf Therapeutics announced its Q4 and full-year 2025 financial results, highlighting a reduced net loss and operational expenses compared to 2024. The company revealed its decision to explore strategic alternatives, including potential sale, merger, or collaborations to maximize shareholder value. With $57.1 million in cash at year-end, they e…

Humacyte Announces Fourth Quarter and Year End 2025 Financial Results and Provides Business Update

Humacyte Announces Fourth Quarter and Year End 2025 Financial Results and Provides Business Update

Humacyte, Inc. announced its financial results for Q4 and full year 2025 with revenues of $0.5 million and $2.0 million respectively, driven by the commercial launch of Symvess in the US and strategic international expansion efforts. The company secured a $1.475 million purchase commitment from Saudi Arabia for clinical evaluation and is pursuing r…

Radiopharm Theranostics Doses First Patient in Phase 1 Clinical Study of RAD 402 in Advanced Prostate Cancer

Radiopharm Theranostics Doses First Patient in Phase 1 Clinical Study of RAD 402 in Advanced Prostate Cancer

Radiopharm Theranostics has dosed the first patient in its Phase 1 clinical trial of RAD 402, a monoclonal antibody radiolabeled with Terbium-161, targeting KLK3 for advanced prostate cancer. The trial aims to assess safety, tolerability, biodistribution, and preliminary efficacy, with data from initial dose levels expected by mid-2026. Preclinical…

Markets Remain Jittery After U.S. Iran Deadline Delay, Analyst Says

Markets Remain Jittery After U.S. Iran Deadline Delay, Analyst Says

Equity markets showed limited improvement after U.S. President Donald Trump delayed his deadline on Iran, according to a note from Vital Knowledge. Analyst Adam Crisafulli said the deferment did not spark a broad equity rebound as investors remain anxious about the situation. Reports that the Pentagon may add roughly 10,000 troops to the Middle Eas…

Morgan Stanley Flags Middle East Risk; Siemens Energy Shares Slip

Morgan Stanley Flags Middle East Risk; Siemens Energy Shares Slip

Siemens Energy shares fell after Morgan Stanley removed the company from its curated list of top stock picks, citing relatively higher near-term exposure to potential disruption in the Middle East. The bank retained an Overweight rating and a €166 price target, but highlighted the Gas Services division as particularly sensitive given the region's s…

Markets Whipsawed by a Post: The Fragility of Pricing Amid the Iran Shock

Markets Whipsawed by a Post: The Fragility of Pricing Amid the Iran Shock

A short message on Truth Social from the U.S. president briefly reversed large swaths of market pricing, sending oil sharply lower and lifting equities before gains faded. Subsequent extensions of an attack deadline and conflicting reports from mediators and Tehran left traders struggling to gauge the trajectory of the crisis, producing volatile mo…

Siemens Energy Loses Morgan Stanley Top-Pick Status as Middle East Exposure Raises Near-Term Concerns

Siemens Energy Loses Morgan Stanley Top-Pick Status as Middle East Exposure Raises Near-Term Concerns

Morgan Stanley removed Siemens Energy from its list of top stock picks while retaining an Overweight rating and a €166 price target, citing heightened near-term risk from the company’s exposure to the Middle East. The bank highlighted the Gas Services division as particularly vulnerable, given the region's substantial contribution to recent order i…